| Ytd | -10.27% | |
| 1y | -29.56% |
| Open | 3.66 | Prev Close | 3.67 | Low | 3.61 | High | 4.04 | Mkt Cap | 1.95B |
| Vol | 35.56M | Avg Vol | 16.93M | EPS | -1.16 | P/E | N/A | Forward P/E | -4.18 |
| Beta | 1.00 | Short Ratio | 8.63 | Inst. Own | 68.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.32 | 200-d Avg | 4.10 | 1yr Est | 6.64 |
RXRX News
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A de
Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities ar
Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology c
Recursion Pharmaceuticals' approach to drug discovery could advance the industry. Fiverr is implemen
Morgan Stanley analyst Vikram Purohit maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Eq
Recursion Pharmaceuticals to update on FDA trial design for REC-4881 for FAP in the second half of 2
Needham analyst Gil Blum reiterates Recursion Pharmaceuticals (NASDAQ:RXRX) with a Buy and mainta
Recursion Pharmaceuticals (NASDAQ:RXRX) reported quarterly losses of $(0.22) per share which beat th
JP Morgan analyst Priyanka Grover maintains Recursion Pharmaceuticals (NASDAQ:RXRX) with a Overwe
ARK's 2025 winners included Robinhood, AMD and Palantir, while its losers were The Trade Desk, R
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,
Cathie Wood-led Ark Invest executed several significant trades on Wednesday, with notable activity i
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshapi
Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 milli
Recursion (NASDAQ:RXRX) a leading clinical stage TechBio company decoding biology to radically impro
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective an
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TL
Several stocks in the health care technology space are moving higher after the market close on Thurs
Fiserv recently completed its acquisition of Payfare Inc. On "Mad Money Lightning Round," Ji
https://www.sec.gov/Archives/edgar/data/1065521/000106299325002489/xslForm13F_X02/form13fInfoTable.x
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
Shares of Etsy, Inc.
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pr
Friday's session saw 104 companies set new 52-week lows.
On Thursday, 185 companies achieved new lows for the year.